Webinars8.20.21
Patent Linkage Opens in China: Dispute Mechanisms and Enforcement Best Practices

China’s National Intellectual Property Administration (CNIPA) and National Medical Products Administration (NAMPA) recently promulgated a new final rule for disputes involving drug patents.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
